These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35996318)
21. Lipid nanoparticles to silence androgen receptor variants for prostate cancer therapy. Quick J; Santos ND; Cheng MHY; Chander N; Brimacombe CA; Kulkarni J; van der Meel R; Tam YYC; Witzigmann D; Cullis PR J Control Release; 2022 Sep; 349():174-183. PubMed ID: 35780952 [TBL] [Abstract][Full Text] [Related]
22. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling. Deep G; Gangar SC; Oberlies NH; Kroll DJ; Agarwal R Mol Carcinog; 2010 Oct; 49(10):902-12. PubMed ID: 20721970 [TBL] [Abstract][Full Text] [Related]
24. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells. Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687 [TBL] [Abstract][Full Text] [Related]
25. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S; Agoulnik IU; Weigel NL Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350 [TBL] [Abstract][Full Text] [Related]
26. The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer. Shamaladevi N; Araki S; Lyn DA; Ayyathurai R; Gao J; Lokeshwar VB; Navarrete H; Lokeshwar BL Oncotarget; 2016 Dec; 7(51):84201-84213. PubMed ID: 27705939 [TBL] [Abstract][Full Text] [Related]
27. Antitumor mechanism of combination of Angelica gigas and Torilis japonica in LNCaP prostate cancer cells via G1 arrest and inhibition of Wnt/β-catenin and androgen receptor signaling. Kim DH; Im E; Lee DY; Lee HJ; Sim DY; Park JE; Ahn CH; Koo JI; Pak JN; Kim SH Phytother Res; 2022 Jul; 36(7):2999-3008. PubMed ID: 35634973 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Narayanan BA; Narayanan NK; Re GG; Nixon DW Int J Cancer; 2003 Mar; 104(2):204-12. PubMed ID: 12569576 [TBL] [Abstract][Full Text] [Related]
29. The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor. Mizokami A; Koh E; Fujita H; Maeda Y; Egawa M; Koshida K; Honma S; Keller ET; Namiki M Cancer Res; 2004 Jan; 64(2):765-71. PubMed ID: 14744796 [TBL] [Abstract][Full Text] [Related]
30. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells. Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564 [TBL] [Abstract][Full Text] [Related]
31. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA]. Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562 [TBL] [Abstract][Full Text] [Related]
32. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503 [TBL] [Abstract][Full Text] [Related]
33. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells. Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674 [TBL] [Abstract][Full Text] [Related]
34. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. Gupta K; Thakur VS; Bhaskaran N; Nawab A; Babcook MA; Jackson MW; Gupta S PLoS One; 2012; 7(12):e52572. PubMed ID: 23285096 [TBL] [Abstract][Full Text] [Related]
35. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
36. A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo. Zhang Y; Shaik AA; Xing C; Chai Y; Li L; Zhang J; Zhang W; Kim SH; Lü J; Jiang C Invest New Drugs; 2012 Oct; 30(5):1820-9. PubMed ID: 21870073 [TBL] [Abstract][Full Text] [Related]
37. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer. Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261 [TBL] [Abstract][Full Text] [Related]
38. Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells. Rosati R; Chen B; Patki M; McFall T; Ou S; Heath E; Ratnam M; Qin Z Mol Pharmacol; 2016 Sep; 90(3):225-37. PubMed ID: 27382012 [TBL] [Abstract][Full Text] [Related]
39. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants. Korkmaz CG; Frønsdal K; Zhang Y; Lorenzo PI; Saatcioglu F J Endocrinol; 2004 Sep; 182(3):377-89. PubMed ID: 15350180 [TBL] [Abstract][Full Text] [Related]
40. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen. Weber H; Ruoff R; Garabedian MJ PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]